The Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 1015 Lausanne, Switzerland.
Trends Immunol. 2013 Jul;34(7):350-9. doi: 10.1016/j.it.2013.02.003. Epub 2013 Mar 13.
Deregulation of microRNAs (miRNAs) can drive oncogenesis, tumor progression, and metastasis by acting cell-autonomously in cancer cells. However, solid tumors are also infiltrated by large amounts of non-neoplastic stromal cells, including macrophages, which express several active miRNAs. Tumor-associated macrophages (TAMs) enhance angiogenic, immunosuppressive, invasive, and metastatic programming of neoplastic tissue and reduce host survival. Here, we review the role of miRNAs (including miR-155, miR-146, and miR-511) in the control of macrophage production and activation, and examine whether reprogramming miRNA activity in TAMs and/or their precursors might be effective for controlling tumor progression.
miRNAs 的失调可通过在癌细胞中自主发挥作用而驱动癌发生、肿瘤进展和转移。然而,实体瘤也被大量非肿瘤性基质细胞浸润,包括巨噬细胞,其表达多种活跃的 miRNAs。肿瘤相关巨噬细胞(TAMs)增强了新生组织的血管生成、免疫抑制、侵袭和转移程序,并降低了宿主的存活率。在这里,我们综述了 miRNAs(包括 miR-155、miR-146 和 miR-511)在控制巨噬细胞产生和激活中的作用,并研究了在 TAMs 和/或其前体细胞中重新编程 miRNA 活性是否可能有效控制肿瘤进展。